In a major step towards advancing biomedical research and innovative therapies, Abu Dhabi Biobank and Mediclinic Middle East have collaborated to expand access to public cord blood donation services, empowering families to contribute to the scientific discovery and development of life-saving treatments that can improve patients’ quality of life worldwide. This expansion adds to Abu Dhabi Biobank’s growing network of partner hospitals which has tripled since May 2025.

Also Read: ELPEN establishes 1st MEA subsidiary to expand access to high quality medicines across the region

Cord blood, collected immediately after birth from the umbilical cord, contains rich hematopoietic stem cells capable of regenerating blood and immune system tissues. Globally, these stem cells have been used in more than 60,000 transplants to treat over 80 life-threatening diseases including leukemia, lymphoma, and various immune deficiencies. For families with genetic disorders such as thalassemia or sickle cell anemia – conditions that are acutely prevalent in the region – cord blood stem cells represent a viable medical resource.

Paul Downey, General Manager, Abu Dhabi Biobank said, “Cord blood stem cells are among the most powerful tools in regenerative medicine. Our partnership with Mediclinic Middle East ensures that every family can either choose to donate their baby’s umbilical cord or preserve this unique biological resource for their own family, potentially saving lives. Together, we are turning scientific potential into practical reality for parents across the UAE.”

Click here to join our WhatsApp channel here

Emphasizing the value of the partnership for expectant parents,Dr. Jacques Kobersy, Chief Medical Officer, Mediclinic Middle East, said: “The birth of a child represents hope and possibility, and cord blood banking allows families to preserve a small piece of that hope for the future. Through this collaboration, we are giving parents clear access to reliable information, seamless collection and storage, and the assurance that their child’s stem cells are preserved safely within the UAE. Our expert physician teams are committed to support the expansion of the program and contribute to advanced medical research in the UAE.”